Moore Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Moore Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-41,925	Closed	-$2.17M	–	513
2024 Q3	$2.17M	Buy	+41,925	New	+$1.97M	0.04%	298
2020 Q1	–	Sell	-160,116	Closed	-$10.3M	–	176
2019 Q4	$10.3M	Sell	160,116 -39,709	-20%	-$2.27M	0.34%	85
2019 Q3	$10.1M	Buy	199,825 +86,910	+77%	+$4.08M	0.4%	76
2019 Q2	$5.12M	Sell	112,915 -52,337	-32%	-$2.44M	0.12%	157
2019 Q1	$7.88M	Sell	165,252 -128,493	-44%	-$6.4M	0.24%	109
2018 Q4	$15.3M	Buy	+293,745	New	+$15.8M	0.6%	29
2018 Q2	–	Sell	-178,083	Closed	-$11.3M	–	261
2018 Q1	$11.3M	Sell	178,083 -14,057	-7%	-$904K	0.23%	100
2017 Q4	$11.8M	Buy	192,140 +50,115	+35%	+$3.13M	0.21%	105
2017 Q3	$9.05M	Buy	142,025 +31,205	+28%	+$1.82M	0.18%	107
2017 Q2	$6.17M	Buy	+110,820	New	+$6.03M	0.19%	112
2016 Q1	–	Sell	-260,000	Closed	-$17.9M	–	250
2015 Q4	$17.9M	Buy	+260,000	New	+$17.2M	0.55%	48
2015 Q2	–	Sell	-60,000	Closed	-$3.87M	–	427
2015 Q1	$3.87M	Buy	+60,000	New	+$3.76M	0.09%	202

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Moore Capital Management's BMY Position: Q4 2024 in Review

Moore Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 41,925 shares — an estimated $2.17M sold.

Moore Capital Management first reported a position in BMY in Q1 2015 and held it in 12 quarters. The position peaked at $17.9M in Q4 2015. 2,486 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

Moore Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
Moore Capital Management sold 41,925 Bristol-Myers Squibb shares in Q4 2024, an estimated $2.17M.
Moore Capital Management first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 12 quarters.
Moore Capital Management's Bristol-Myers Squibb position peaked at $17.9M in Q4 2015.
2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Moore Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.